<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pfizer Archives - UK Investor Magazine</title>
	<atom:link href="https://ukinvestormagazine.co.uk/tag/pfizer/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/tag/pfizer/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Fri, 15 Jan 2021 16:00:08 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.4</generator>

<image>
	<url>https://ukinvestormagazine.co.uk/wp-content/uploads/2025/05/cropped-favicon-96-96-32x32.jpg</url>
	<title>Pfizer Archives - UK Investor Magazine</title>
	<link>https://ukinvestormagazine.co.uk/tag/pfizer/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Pfizer shares slide on vaccine delivery cuts</title>
		<link>https://ukinvestormagazine.co.uk/pfizer-shares-slide-on-vaccine-delivery-cuts/</link>
					<comments>https://ukinvestormagazine.co.uk/pfizer-shares-slide-on-vaccine-delivery-cuts/#respond</comments>
		
		<dc:creator><![CDATA[Bronte Carvalho]]></dc:creator>
		<pubDate>Fri, 15 Jan 2021 15:57:31 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[COVID vaccine]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[share price]]></category>
		<category><![CDATA[shares dip]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[vaccines]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=34403</guid>

					<description><![CDATA[<img width="300" height="207" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-300x207.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-300x207.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-768x531.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-150x104.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-218x150.jpg 218w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-436x300.jpg 436w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-600x415.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-696x481.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-608x420.jpg 608w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts-100x70.jpg 100w, https://ukinvestormagazine.co.uk/wp-content/uploads/2021/01/Pfizer-shares-slide-on-vaccine-delivery-cuts.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Shares at American pharmaceutical firm Pfizer (NYSE:PFE) have slipped after its announcement that it will be temporary reducing deliveries of its Covid-19 vaccine to Europe while it seeks to upgrade its production capacity to the target 2 billion doses per year. “This temporary reduction will affect all European countries,” a spokeswoman for Pfizer Denmark said [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/pfizer-shares-slide-on-vaccine-delivery-cuts/">Pfizer shares slide on vaccine delivery cuts</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/pfizer-shares-slide-on-vaccine-delivery-cuts/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Vaccines to be flown in by military aircraft to avoid Brexit delays</title>
		<link>https://ukinvestormagazine.co.uk/vaccines-to-be-flown-in-by-military-aircraft-to-avoid-brexit-delays/</link>
					<comments>https://ukinvestormagazine.co.uk/vaccines-to-be-flown-in-by-military-aircraft-to-avoid-brexit-delays/#respond</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Sat, 05 Dec 2020 23:11:28 +0000</pubDate>
				<category><![CDATA[Politics]]></category>
		<category><![CDATA[BioNTech]]></category>
		<category><![CDATA[Boris Johnson]]></category>
		<category><![CDATA[Brexit]]></category>
		<category><![CDATA[EU]]></category>
		<category><![CDATA[MoD]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[politics]]></category>
		<category><![CDATA[Ursula von der Leyen]]></category>
		<category><![CDATA[vaccines]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=33467</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-150x100.jpg 150w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-600x400.jpg 600w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-696x464.jpg 696w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/12/UK-military-aircraft.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>According to contingency plans being developed by the UK government, ‘tens of millions’ of vaccines produced in Belgium will be flown into Britain via military aircraft, to sidestep customs delays caused by the Brexit transition. MoD and Department of Health and Social Care sources told the Observer that ‘large consignments’ of vaccines would be brought [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/vaccines-to-be-flown-in-by-military-aircraft-to-avoid-brexit-delays/">Vaccines to be flown in by military aircraft to avoid Brexit delays</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/vaccines-to-be-flown-in-by-military-aircraft-to-avoid-brexit-delays/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Global equities in mixed minds about vaccine, retail sales and US stimulus</title>
		<link>https://ukinvestormagazine.co.uk/global-equities-in-mixed-minds-about-vaccine-retail-sales-and-us-stimulus/</link>
					<comments>https://ukinvestormagazine.co.uk/global-equities-in-mixed-minds-about-vaccine-retail-sales-and-us-stimulus/#respond</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Fri, 20 Nov 2020 17:39:16 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Politics]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Black Friday]]></category>
		<category><![CDATA[CAC]]></category>
		<category><![CDATA[DAX]]></category>
		<category><![CDATA[DOW Jones]]></category>
		<category><![CDATA[Fed]]></category>
		<category><![CDATA[FTSE]]></category>
		<category><![CDATA[global equities]]></category>
		<category><![CDATA[index]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[online shopping]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[retail sales]]></category>
		<category><![CDATA[stimulus]]></category>
		<category><![CDATA[treasury]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32873</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Global-equities-trading-floor.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Unsure of what to do with themselves after a mixed week, global equities posted relatively modest movements as they responded to a varied bag of news updates on vaccine updates, retail sales and US stimulus. Between Pfizer and Moderna one-upping each-other with positive news, markets have been spurred on since the booming US election week. [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/global-equities-in-mixed-minds-about-vaccine-retail-sales-and-us-stimulus/">Global equities in mixed minds about vaccine, retail sales and US stimulus</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/global-equities-in-mixed-minds-about-vaccine-retail-sales-and-us-stimulus/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>FTSE stunted as pound gains on Brexit hopes</title>
		<link>https://ukinvestormagazine.co.uk/ftse-stunted-as-pound-gains-on-brexit-hopes/</link>
					<comments>https://ukinvestormagazine.co.uk/ftse-stunted-as-pound-gains-on-brexit-hopes/#respond</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Wed, 18 Nov 2020 16:47:46 +0000</pubDate>
				<category><![CDATA[Commodities/FX]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Politics]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Brexit]]></category>
		<category><![CDATA[CAC]]></category>
		<category><![CDATA[currency]]></category>
		<category><![CDATA[DAX]]></category>
		<category><![CDATA[dollar]]></category>
		<category><![CDATA[DOW Jones]]></category>
		<category><![CDATA[euro]]></category>
		<category><![CDATA[FTSE]]></category>
		<category><![CDATA[FX]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pound]]></category>
		<category><![CDATA[Sterling]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32766</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/11/Pound-FTSE-Brexit.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>While not moving quite as enthusiastically as they did after previous vaccine updates, Pfizer&#8216;s latest news saw global equities nudge higher on Wednesday. Noticeably muted, though, was the FTSE. Having led the pack in recent vaccine news rallies, the index was weighed the pound rising on renewed Brexit hopes. While the Dow Jones rallied by [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/ftse-stunted-as-pound-gains-on-brexit-hopes/">FTSE stunted as pound gains on Brexit hopes</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/ftse-stunted-as-pound-gains-on-brexit-hopes/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Have Tech Stocks had their day in the sun?</title>
		<link>https://ukinvestormagazine.co.uk/have-tech-stocks-had-their-day-in-the-sun/</link>
					<comments>https://ukinvestormagazine.co.uk/have-tech-stocks-had-their-day-in-the-sun/#comments</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Wed, 11 Nov 2020 16:21:25 +0000</pubDate>
				<category><![CDATA[Features]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[Alibaba]]></category>
		<category><![CDATA[Alphabet]]></category>
		<category><![CDATA[Amazon]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[big tech]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[equities]]></category>
		<category><![CDATA[Just Eat]]></category>
		<category><![CDATA[Microsoft]]></category>
		<category><![CDATA[Ocado]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[tech stocks]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32553</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/07/Fortune-500-data-scientist-tech-gold-predictions.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Pfizer&#8217;s vaccine announcement saw gold and gilts sell off, while European equities rallied by 5% on Monday. Meanwhile, the tech stocks that boomed during the pandemic &#8211; and last week &#8211; saw the Nasdaq drop by 1.5% on the same day as Eurozone markets flew. Fast-rising home delivery stocks, Ocado and Just Eat, shed 5.21% [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/have-tech-stocks-had-their-day-in-the-sun/">Have Tech Stocks had their day in the sun?</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/have-tech-stocks-had-their-day-in-the-sun/feed/</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
			</item>
		<item>
		<title>Three reasons why New Year’s Eve may be an eventful time for equities</title>
		<link>https://ukinvestormagazine.co.uk/three-reasons-why-new-years-eve-may-be-an-eventful-time-for-equities/</link>
					<comments>https://ukinvestormagazine.co.uk/three-reasons-why-new-years-eve-may-be-an-eventful-time-for-equities/#comments</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Wed, 28 Oct 2020 23:37:22 +0000</pubDate>
				<category><![CDATA[Commodities/FX]]></category>
		<category><![CDATA[Features]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Biden]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[election]]></category>
		<category><![CDATA[equities]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Hogmanay]]></category>
		<category><![CDATA[lockdown]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[New Year's Eve]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[presidents]]></category>
		<category><![CDATA[restrictions]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[Trump]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32132</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/10/New-Years-Eve.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>It’s still an election, twenty new COVID policy measures, and a Christmas dinner away, but its worth trying to anticipate what equities will look like as the clock strikes midnight on New Year’s Eve. And, here are three factors to consider. The Christmas COVID Crunch Despite the police commissioner’s misguided tough guy comments about breaking [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/three-reasons-why-new-years-eve-may-be-an-eventful-time-for-equities/">Three reasons why New Year’s Eve may be an eventful time for equities</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/three-reasons-why-new-years-eve-may-be-an-eventful-time-for-equities/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>GlaxoSmithKline round off excellent 2019 with bullish fourth quarter update</title>
		<link>https://ukinvestormagazine.co.uk/glaxosmithkline-round-off-excellent-2019-with-bullish-fourth-quarter-update/</link>
					<comments>https://ukinvestormagazine.co.uk/glaxosmithkline-round-off-excellent-2019-with-bullish-fourth-quarter-update/#respond</comments>
		
		<dc:creator><![CDATA[Ishen Patel]]></dc:creator>
		<pubDate>Wed, 05 Feb 2020 14:01:15 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[Shares]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=26854</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2020/02/shutterstock_1168320490.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>GlaxoSmithKline (LON:GSK) have seen their profits rise across 2019 as the pharmaceutical titan updated the market on its 2019 and fourth quarter operations. Glaxo alluded to the improvements particularly in its vaccines and consumer health segments, and also the benefits exploited from its mutual venture with Pfizer (NYSE:PFE). The pharmaceutical giant said that it had [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/glaxosmithkline-round-off-excellent-2019-with-bullish-fourth-quarter-update/">GlaxoSmithKline round off excellent 2019 with bullish fourth quarter update</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/glaxosmithkline-round-off-excellent-2019-with-bullish-fourth-quarter-update/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Indivior releases new treatment, shares dip with copycat fears</title>
		<link>https://ukinvestormagazine.co.uk/indivior-releases-new-treatment-shares-dip-with-copycat-fears/</link>
					<comments>https://ukinvestormagazine.co.uk/indivior-releases-new-treatment-shares-dip-with-copycat-fears/#respond</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Wed, 20 Feb 2019 11:16:40 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[Addiction treatment]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[Indivior]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=18402</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2019/02/Indivior-opioid-treatment.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>FTSE 250 specialist pharmaceutical company Indivior Plc (LON:INDV) announced on Wednesday that it has released an authorised generic version of its treatment to combat opioid addiction. The treatment has been released in the US market in an attempt to combat the anticipated impact of rival companies launching &#8216;copycat&#8217; products. The decision to launch the treatment [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/indivior-releases-new-treatment-shares-dip-with-copycat-fears/">Indivior releases new treatment, shares dip with copycat fears</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/indivior-releases-new-treatment-shares-dip-with-copycat-fears/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Pfizer shares rally following talks with Trump</title>
		<link>https://ukinvestormagazine.co.uk/pfizer-shares-rally-following-talks-with-trump/</link>
					<comments>https://ukinvestormagazine.co.uk/pfizer-shares-rally-following-talks-with-trump/#comments</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Wed, 11 Jul 2018 09:44:40 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Trump]]></category>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=12767</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-300x200.jpg 300w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-768x512.jpg 768w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-630x420.jpg 630w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-537x360.jpg 537w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-640x427.jpg 640w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque-681x454.jpg 681w, https://ukinvestormagazine.co.uk/wp-content/uploads/2018/07/Pfizer-HQ-plaque.jpg 1000w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p>Pfizer Inc. (LON:PFE) shares have rallied this morning, following talks with President Trump and an agreement to defer its scheduled price increases. The pharmaceutical giant is one of many firms that implements incremental drug price hikes every half year. However, after being singled out among &#8220;others&#8221; in a tweet by President Trump on Monday, the [&#8230;]</p>
<p>The post <a href="https://ukinvestormagazine.co.uk/pfizer-shares-rally-following-talks-with-trump/">Pfizer shares rally following talks with Trump</a> appeared first on <a href="https://ukinvestormagazine.co.uk">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestormagazine.co.uk/pfizer-shares-rally-following-talks-with-trump/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
	</channel>
</rss>
